Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Comparison of Liposomal Anthracycline Based Treatment Versus Conventional Care Strategies Before Allogeneic Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML

NCT04061239 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT04061239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04061239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Comparison of Liposomal Anthracycline Based Treatment Versus Conventional Care Strategies Before Allogeneic Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
Lead sponsor
GWT-TUD GmbH
Phase
Phase 2
Overall status
Completed
Start date
August 19, 2019
Completion date
August 7, 2026
Enrollment
150 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

aml, mds